New minimally invasive diagnostic technology for brain cancers
Currently, there is no way to accurately diagnose the presence of brain tumors without actually cutting into the skull. Nor is there a reliable method for monitoring the progression of brain cancer. But in a paper, published online in the journal Neuro-Oncology, an international group of researchers at UC San Diego Moores Cancer Center, the Brigham and Women’s Hospital and Georg-August University in Germany describe a non-surgical method that may do both with remarkable accuracy.             In a study of 118 patients with different types of brain cancers, researchers focused on the presence and abundance of different microRNAs in patients’ cerebrospinal fluid (CSF).  MicroRNAs are short, single-stranded RNA molecules that help regulate gene expression. They have proven to be effective biomarkers for other conditions and can be accurately measured simply and inexpensively.            That utility appears to hold true for brain cancer as well. The scientists report that they found significantly increased levels of two specific types of miRNA in the CSF of patients with glioblastoma and brain metastasis of breast and lung cancer, compared to tumors in remission and a variety of non-neoplastic conditions.             Patients with brain metastases but no other pathologic conditions showed highly elevated levels of other types of miRNA, allowing researchers to discriminate between glioblastoma and metastatic brain tumors.            The scientists were able to achieve these diagnoses by measuring as few as seven miRNAs. Their accuracy rate was very high: 91 to 99 percent.            In addition, they reported that disease activity and treatment response can be monitored by regularly profiling microRNA levels in the CSF of glioblastoma and non-small cell lung carcinoma patients.            "This is just the beginning,” said co-senior author Santosh Kesari, MD, PhD, director of Neuro-Oncology and Translational Neuro-Oncology Laboratories at UC San Diego. “We will continue to lead discovers of novel biomarkers in CSF, blood and other body fluids using the latest technologies to better detect oncological and neurological diseases which will allow us to optimize outcomes in our patients.”
“The test needs to be further developed before it is used in a clinical setting,” said Kesari, “but I expect it could be particularly valuable for patients who are not surgical candidates due to the tumor’s size or location, or due to an underlying medical condition.”            Scott Lippman, MD, the new director of the UC San Diego Moores Cancer Center, lauded the international collaboration and its potential: “This work exemplifies our renewed emphasis on translating molecular discovery into clinical advances that improve the lives of patients here and worldwide.”

New minimally invasive diagnostic technology for brain cancers

Currently, there is no way to accurately diagnose the presence of brain tumors without actually cutting into the skull. Nor is there a reliable method for monitoring the progression of brain cancer. But in a paper, published online in the journal Neuro-Oncology, an international group of researchers at UC San Diego Moores Cancer Center, the Brigham and Women’s Hospital and Georg-August University in Germany describe a non-surgical method that may do both with remarkable accuracy.
           
In a study of 118 patients with different types of brain cancers, researchers focused on the presence and abundance of different microRNAs in patients’ cerebrospinal fluid (CSF).  MicroRNAs are short, single-stranded RNA molecules that help regulate gene expression. They have proven to be effective biomarkers for other conditions and can be accurately measured simply and inexpensively.
           
That utility appears to hold true for brain cancer as well. The scientists report that they found significantly increased levels of two specific types of miRNA in the CSF of patients with glioblastoma and brain metastasis of breast and lung cancer, compared to tumors in remission and a variety of non-neoplastic conditions.
           
Patients with brain metastases but no other pathologic conditions showed highly elevated levels of other types of miRNA, allowing researchers to discriminate between glioblastoma and metastatic brain tumors.
           
The scientists were able to achieve these diagnoses by measuring as few as seven miRNAs. Their accuracy rate was very high: 91 to 99 percent.
           
In addition, they reported that disease activity and treatment response can be monitored by regularly profiling microRNA levels in the CSF of glioblastoma and non-small cell lung carcinoma patients.
           
"This is just the beginning,” said co-senior author Santosh Kesari, MD, PhD, director of Neuro-Oncology and Translational Neuro-Oncology Laboratories at UC San Diego. “We will continue to lead discovers of novel biomarkers in CSF, blood and other body fluids using the latest technologies to better detect oncological and neurological diseases which will allow us to optimize outcomes in our patients.”

“The test needs to be further developed before it is used in a clinical setting,” said Kesari, “but I expect it could be particularly valuable for patients who are not surgical candidates due to the tumor’s size or location, or due to an underlying medical condition.”
           
Scott Lippman, MD, the new director of the UC San Diego Moores Cancer Center, lauded the international collaboration and its potential: “This work exemplifies our renewed emphasis on translating molecular discovery into clinical advances that improve the lives of patients here and worldwide.”

Notes

  1. apichiro reblogged this from fuckyeahmedicalstuff
  2. madridkid reblogged this from ucsdhealthsciences
  3. let-me-see-the-flowers reblogged this from ucsdhealthsciences
  4. halc6 reblogged this from ucsdhealthsciences
  5. crazysven reblogged this from fuckyeahmedicalstuff
  6. ovarydoses reblogged this from flowersfromdirt-
  7. whensavagesunite reblogged this from ucsdhealthsciences
  8. bonitafish reblogged this from fuckyeahmedicalstuff
  9. dr-acidcute reblogged this from fuckyeahmedicalstuff
  10. heynice reblogged this from ucsdhealthsciences
  11. midgetmonkey reblogged this from fuckyeahmedicalstuff
  12. unexpectedintelligence reblogged this from ciudad-acida
  13. ciudad-acida reblogged this from ucsdhealthsciences
  14. tfrencel reblogged this from ucsdhealthsciences
  15. tdental reblogged this from ucsdhealthsciences
  16. kristinadeee reblogged this from fuckyeahmedicalstuff
  17. puzzlepiecez reblogged this from everfallinlove
  18. vanessaintheskywithdiamonds reblogged this from fuckyeahmedicalstuff
  19. whereisthebepis reblogged this from ucsdhealthsciences
  20. soomewhereovertherainbow reblogged this from ucsdhealthsciences
  21. attentiontodisorder reblogged this from passion-for-medicine
  22. alifmuhd reblogged this from ucsdhealthsciences
  23. life-forces-maybe reblogged this from fuckyeahmedicalstuff
  24. aloneabovearagingsea reblogged this from fuckyeahmedicalstuff
  25. everfallinlove reblogged this from endothelium
  26. toccata-carpimusnoctem reblogged this from madokarp
  27. madokarp reblogged this from fuckyeahmedicalstuff
  28. passion-for-medicine reblogged this from aspiringdoctors
  29. mclaros reblogged this from aspiringdoctors
  30. aspiringdoctors reblogged this from fuckyeahmedicalstuff
  31. mediamed reblogged this from ucsdhealthsciences and added:
    Chercher le microARN pour dépister les tumeurs cérébrales
  32. xtinastat reblogged this from ucsdhealthsciences
  33. pinksoda reblogged this from ucsdhealthsciences

About

News from UC San Diego Health Sciences
Media Contacts: 619-543-6163
HealthSciComm@ucsd.edu

Blogroll

  • missmdisme
  • seltzerlizard
  • huffingtonpost
  • comedycentral
  • md-admissions
  • soupsoup
  • jtotheizzoe
  • scientificillustration
  • boston
  • wnyc
  • afro-dominicano
  • azspot
  • melon-collies
  • mathcat345
  • fastcompany
  • scienceyoucanlove
  • mothernaturenetwork
  • newyorker
  • salon
  • breakingnews
  • oupacademic
  • neurosciencestuff
  • pubhealth
  • artpoweratucsd
  • latimes
  • wayfaringmd
  • inothernews
  • biocanvas
  • yahoonews
  • washingtonpost
  • kqedscience
  • medicalstate
  • thisissandiego
  • tballardbrown
  • ucsdzone
  • think-progress
  • nursefocker
  • mindblowingscience
  • libertasacademica
  • prnewswire
  • wsudiscovery
  • pbstv
  • blamoscience
  • todaysdocument
  • theonion
  • theweekmagazine
  • aspiringdoctors
  • medresearch
  • publicradiointernational
  • staff
  • science-and-logic
  • longform
  • thevancouversun
  • currentsinbiology
  • amnhnyc
  • sdzoo
  • photojojo
  • guardian
  • exploratorium
  • ucsdcrossculturalcenter
  • cancerninja
  • newsweek
  • jayparkinsonmd
  • wired
  • scishow
  • prochoiceamerica
  • forbes
  • buzzfeed
  • sciencefriday
  • shortformblog
  • science-junkie
  • nysci
  • nbcnightlynews
  • alscientist
  • rollingstone
  • nprfreshair
  • explore-blog
  • ucsdcancer
  • ucsdspecialcollections
  • npr
  • plannedparenthood
  • thebrainscoop
  • queerability
  • scipak
  • sdzsafaripark
  • newswatchtv
  • nprglobalhealth
  • thisisfusion
  • skunkbear
  • onaissues
  • instagram
  • forum-network
  • doctorswithoutborders
  • science
  • thescienceblog
  • therumpus
  • actgnetwork
  • ucresearch
  • medicalschool
  • scienceandfood
  • usagov
  • pulitzercenter
  • infographicjournal
  • nydailynews
  • researchchla
  • mashablehq
  • wnycradiolab
  • lakeconews
  • sciencenetlinks
  • 3rdofmay
  • uconnhealthlib
  • medindia
  • doublejack
  • colchrishadfield
  • pozmagazine
  • dodgemedlin
  • madsweat
  • yaleuniversity
  • nypl
  • sesamestreet
  • today
  • stemcellculture
  • statedept
  • scienceisbeauty
  • cranquis
  • smithsonianmag
  • abcworldnews
  • katiecouric
  • newshour
  • psychotherapy
  • robertreich
  • scientificthought
  • pritheworld
  • bbsrc
  • msnbc
  • pbsthisdayinhistory
  • scinerds
  • ari-abroad
  • americanpublicmedia
  • ucsciencetoday
  • austinstatesman
  • post-mitotic
  • artandsciencejournal
  • journalofajournalist
  • princeton-medbloro
  • usatoday
  • artneuroscience
  • highcountrynews
  • codeit
  • minnpost
  • csmonitor
  • oceanportal
  • kpcc
  • ucrhub
  • cenwatchglass
  • thedailyshow
  • fuckyeahcardiovascularsystem
  • mediclopedia
  • ohscience
  • bbglasses
  • natgeofound
  • usnews
  • officialssay
  • cnbc
  • ottawahealth
  • anaofta
  • fuckyeahneuroscience
  • fyeahmedlab
  • washingtonexaminer
  • unicef
  • houseofmind
  • brookhavenlab
  • timelightbox
  • ziyadnazem
  • lewisandquark
  • whitehouse
  • lookatthisstory
  • columbusdispatch
  • hospitalreina
  • articulomortis
  • laboratoryequipment
  • peacecorps
  • nprontheroad
  • sciencesoup
  • healthcareinfoguide
  • theskygazer
  • timemagazine
  • aarp
  • nbcnews
  • psydoctor8
  • tmagazine
  • shortyawards
  • molecularlifesciences
  • markcoatney
  • reuters
  • blue-lights-and-tea
  • htdeverything
  • mediamed
  • phdr
  • topherchris
  • kateoplis
  • denverpost
  • motherjones
  • discoverynews
  • michiganengineering
  • oh4theloveofscience
  • nurse-on-duty
  • thenewrepublic
  • wgbhnews
  • theatlantic
  • fuckyeahnervoussystem
  • sciencenote
  • matthewkeys
  • robotmuesli
  • pneupnurse
  • medethicslady
  • themedicalchronicles
  • ohyeahdevelopmentalbiology
  • ucsdcareerservicescenter
  • pacificstand
  • clearscience
  • bitesizedbiology
  • poptech
  • futureofscience
  • galindoyadira
  • genannetics
  • ucsd
  • ucsdmedialab
  • joshherigon
  • thescienceofreality
  • ladyjournos
  • sciencechicks
  • auditoryinsomniac
  • chronicleofhighered
  • vetstail
  • neurolove
  • ajebsary
  • neuroanatomyblog
  • goodideapublichealth
  • tedx
  • huffpostscience
  • thecoloradopursuit
  • brainmtters
  • bobedwardsradio
  • paraphyletic
  • sci-fact
  • nationalpost
  • carlzimmer
  • life
  • dailymedical
  • bklynmed
  • wellcomebrains
  • aljazeera
  • reportingonhealth
  • ucsfbioengineering
  • coolhealthinfographics
  • thedailywhat
  • villagevoice
  • nbclatino
  • guardiancomment
  • scientificbritain
  • adschu